Aviva (LON:AV – Free Report) had its price objective raised by Berenberg Bank from GBX 800 to GBX 820 in a report issued on Monday morning,Digital Look reports. The firm currently has a buy rating on the stock.
Other equities analysts have also recently issued reports about the company. UBS Group reiterated a “buy” rating and issued a GBX 750 target price on shares of Aviva in a report on Monday, May 11th. JPMorgan Chase & Co. boosted their price target on shares of Aviva from GBX 715 to GBX 800 and gave the company an “overweight” rating in a research note on Thursday, August 13th. Jefferies Financial Group restated a “hold” rating and set a GBX 637 price objective on shares of Aviva in a report on Friday, May 15th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and issued a GBX 780 price objective on shares of Aviva in a research note on Wednesday, July 29th. Five investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of GBX 733.50.
Read Our Latest Research Report on Aviva
Aviva Stock Performance
Insider Activity at Aviva
In related news, insider Pippa Lambert bought 205 shares of the company’s stock in a transaction dated Monday, August 17th. The shares were bought at an average price of GBX 729 per share, for a total transaction of £1,494.45. Insiders purchased 501 shares of company stock valued at $347,603 over the last three months. Corporate insiders own 0.17% of the company’s stock.
About Aviva
Aviva plc provides various insurance, retirement, investment, and savings products in the United Kingdom, Ireland, Canada, and internationally. The company offers life insurance, long-term health and accident insurance, savings, pension, and annuity products, as well as pension fund business and lifetime mortgage products. It also provides insurance cover to individuals, small and medium-sized businesses for risks associated with motor vehicles and medical expenses, as well as property and liability, such as employers' and professional indemnity liabilities.
Featured Articles
- Five stocks we like better than Aviva
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Aviva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aviva and related companies with MarketBeat.com's FREE daily email newsletter.
